Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected

Marie Tré-Hardy, Roberto Cupaiolo, Alain Wilmet, Thomas Antoine-Moussiaux, Nicoleta Coman-Vlagea, Andrea Della Vecchia, Alexandra Horeanga, Emmanuelle Papleux, Marc Vekemans, Ingrid Beukinga, Laurent Blairon

    Research output: Contribution to journalLetterpeer-review

    Original languageEnglish
    Pages (from-to)e31-e33
    JournalJournal of Infection
    Issue number4
    Publication statusPublished - Apr 2022

    Cite this